Find the Perfect Plan for Your Investment Journey
V
Latest price
52 Week Range
€63.60 - €106.00
Next Earnings Date
Sep 10 2025 (Estimate)
Next Earnings Date
Sep 10 2025 (Est.)
Latest price
Market Cap | €934.77M |
EV | €792.92M |
Shares Outstanding | 11.83M |
Beta | 0.88 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | €93.71 |
P/E 2025E | 14.76x |
P/Revenue 2025E | 1.63x |
Revenue | 1.10% |
EPS | - |
Operating Cash Flow | -1.50% |
Free Cash Flow | - |
Revenue | 3.70% |
EPS | - |
Operating Cash Flow | -4.50% |
Free Cash Flow | - |
Gross Margin 2025E | 71.73% |
Net Profit Margin 2025E | 11.03% |
ROE 2025E | 9.90% |
ROCE 2024 | - |
DPS 2025E | €0.86 |
Payout Ratio 2025E | 16.54% |
Div. Yield 2025E | 1.12% |
DPS Last 3Y CAGR | 3.60% |
Price
%
1M
3M
6M
1Y
3Y
5Y
V
Vetoquinol SA
VETO
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Frechin, Matthieu
Employees
2,519
Website
www.vetoquinol.comIPO Date
2006-11-17
Headquarters
Magny-Vernois, 34 rue du chêne Sainte Anne, Lure, Franche Comté, 70204, France
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved